Literature DB >> 2103512

Transformation by the human adenoviruses.

N C Jones1.   

Abstract

Oncogenic transformation by the human adenoviruses involves the concerted action of two genes, E1A and E1B. Over the last few years the products of these genes have been characterised in considerable detail using genetic, immunological and biochemical means. The E1A gene by itself can immortalise primary cells and can cooperate to effect full morphological transformation not only with E1B but also with other known oncogenes. The immortalisation and cooperation activities of E1A require multiple functions that are directed by structurally and functionally independent regions of the E1A protein. These regions coincide with sites of protein: protein interaction between E1A and a variety of cellular polypeptides. One of these, the Rb protein, is a known regulator of the mammalian cell cycle. The E1B region encodes two proteins required for transformation, the larger of which binds to the p53 cellular protein. This protein has also been implicated as a negative regulator of cell growth. It appears therefore that E1A and E1B carry out their many functions associated with transformation at least in part by binding to and presumably modulating the activity of key cellular regulators.

Entities:  

Mesh:

Year:  1990        PMID: 2103512

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  5 in total

1.  Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.

Authors:  Ramon A Gonzalez; S J Flint
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Adenovirus E1A-regulated transcription factor p120E4F inhibits cell growth and induces the stabilization of the cdk inhibitor p21WAF1.

Authors:  E R Fernandes; J Y Zhang; R J Rooney
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

3.  The role of nuclear lamin B1 in cell proliferation and senescence.

Authors:  Takeshi Shimi; Veronika Butin-Israeli; Stephen A Adam; Robert B Hamanaka; Anne E Goldman; Catherine A Lucas; Dale K Shumaker; Steven T Kosak; Navdeep S Chandel; Robert D Goldman
Journal:  Genes Dev       Date:  2011-12-08       Impact factor: 11.361

4.  Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1.

Authors:  Pablo J Fernandez-Marcos; Cristina Pantoja; Agueda Gonzalez-Rodriguez; Nicholas Martin; Juana M Flores; Angela M Valverde; Eiji Hara; Manuel Serrano
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

5.  Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers.

Authors:  S Irshad; A-L Mahul-Mellier; N Kassouf; A Lemarie; S Grimm
Journal:  Cell Death Differ       Date:  2009-03-13       Impact factor: 15.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.